Literature DB >> 7026259

Comparative study of the effect of azepexole and clonidine on blood pressure and pulse rate in normotensive subjects.

L Benedikter, T Mey, D A Middleton.   

Abstract

In a double-blind cross-over study in 8 normotensive subjects azepexole was found to have a pharmacological profile identical to that of clonidine, although chemically there is no structural similarity between the two compounds. Compared to placebo, oral azepexole 5 and 10 mg and clonidine 0.15 mg produced a significant reduction in systolic and diastolic blood pressures both supine and standing (tilted). The reduction was greater in the standing than in the supine position. There was a significant slowing of the pulse rate only in the supine position, whereas the reflex increase in pulse rate on tilting was enhanced after both substances. The rise in diastolic blood pressure on tilting, however, was partically blocked by azepexole 10 mg. No dose dependent change in the pulse rate was observed. The maximum fall in blood pressure and pulse rate occurred between 1.5 and 4 h after ingestion of either substance, and had not returned to placebo level after 6 h, except for the supine systolic pressure after azepexole 5 mg. Dose-dependent sedation and dryness of the mouth were observed both after azepexole and clonidine. They followed approximately the same time-course as the haemodynamic changes. Although the hypotensive effect of azepexole 10 mg was larger than that of clonidine 0.15 mg, the orthostatic side-effects were also greater. As the hypotensive effect and side-effects of azepexole 5 mg and 0.15 mg clonidine were almost the same, it seems justifiable to investigate the properties of azepexole in hypertensive patients.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7026259     DOI: 10.1007/bf00615399

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


  16 in total

1.  Involvement of adrenergic receptors in central vagus activity.

Authors:  W Kobinger; A Walland
Journal:  Eur J Pharmacol       Date:  1971-09       Impact factor: 4.432

2.  Effects of clonidine on the baroreceptor-heart rate reflex and on single aortic baroreceptor fibre discharge.

Authors:  P I Korner; J R Oliver; P Sleight; J P Chalmers; J S Robinson
Journal:  Eur J Pharmacol       Date:  1974-09       Impact factor: 4.432

3.  An investigation into the bradycardic effects of ST 155 [2-(2,6-dichlorophenylamino)-2-imidazoline HCl] in the anesthetized dog.

Authors:  R D Robson; H R Kaplan; S Laforce
Journal:  J Pharmacol Exp Ther       Date:  1969-09       Impact factor: 4.030

4.  Further similarities between the action of clonidine and a central activation of the depressor baroreceptor reflex.

Authors:  G Haeusler
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1974       Impact factor: 3.000

5.  Cardiovascular effects of 2-(2,6-dichlorophenylamino)-2-imidazoline hydrochloride (ST 155). II. Central sympathetic structures.

Authors:  H Schmitt; J R Boissier; J F Giudicelli; J Fichelle
Journal:  Eur J Pharmacol       Date:  1968-03       Impact factor: 4.432

6.  Acute hypotensive action of 2-(2,6-dichlorophenylamino)-2-imidazoline hydrochloride (St 155) after infusion into the cat's vertebral artery.

Authors:  R W Sattler; P A van Zwieten
Journal:  Eur J Pharmacol       Date:  1967-10       Impact factor: 4.432

7.  Activation of the central pathway of the baroreceptor reflex, a possible mechanism of the hypotensive action of clonidine.

Authors:  G Haeusler
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1973       Impact factor: 3.000

8.  Action of clonidine on the baroreceptor pathway and medullary sites mediating vagal bradycardia.

Authors:  M Laubie; H Schmitt; M Drouillat
Journal:  Eur J Pharmacol       Date:  1976-08       Impact factor: 4.432

9.  Mechanism of cardiovascular effects of clonidine in conscious and anesthetized rabbits.

Authors:  K K Tangri; M Petty; L M Wing; J L Reid
Journal:  J Pharmacol Exp Ther       Date:  1977-07       Impact factor: 4.030

10.  Localization of the hypotenisve effect of 2-(2-6-dichlorophenylamino)-2-imidazoline hydrochloride (St 155, Catapresan).

Authors:  H Schmitt; H Schmitt
Journal:  Eur J Pharmacol       Date:  1969-04       Impact factor: 4.432

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.